December PBS changes

There have been several changes to the PBS schedule. These are some of the highlights:

An expansion of the affordable treatment options for patients with asthma and COPD with the listing of Breo Ellipta.

Manufactured by GlaxoSmithKline and Theravance, Breo Ellipta is a combination of an inhaled corticosteroid, fluticasone furoate, and a long-acting bronchodilator, vilanterol, administered using the new Ellipta dry powder inhaler.

Breo Ellipta is PBS listed for the treatment of asthma in Australian patients aged 12 years and over.

Latest

Trending